Cargando…
The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
In recent years, Non-Hodgkin lymphoma (NHL) has been one of the most fast-growing malignant tumor diseases. NHL poses severe damages to physical health and a heavy burden to patients. Traditional therapies (chemotherapy or radiotherapy) bring some benefit to patients, but have severe adverse effects...
Autores principales: | Zhou, Tianlin, Peng, Jinrong, Hao, Ying, Shi, Kun, Zhou, Kai, Yang, Yun, Yang, Chengli, He, Xinlong, Chen, Xinmian, Qian, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511651/ https://www.ncbi.nlm.nih.gov/pubmed/33005832 http://dx.doi.org/10.1016/j.bioactmat.2020.09.002 |
Ejemplares similares
-
Macrophage Membrane-Camouflaged shRNA and Doxorubicin: A pH-Dependent Release System for Melanoma Chemo-Immunotherapy
por: Yang, Chengli, et al.
Publicado: (2022) -
Barriers to achieving a cure in lymphoma
por: Kambhampati, Swetha, et al.
Publicado: (2021) -
Primary pulmonary lymphoma in children
por: Wu, Xiaohui, et al.
Publicado: (2019) -
Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy
por: Yang, Yun, et al.
Publicado: (2022) -
Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
por: Chen, Zhenzhen, et al.
Publicado: (2018)